SCHEMBL16373144

SCHEMBL16373144

CCCN1CCc2c(n(C)c3ccccc23)C1c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.47
▸ ABCG2 Q9UNQ0 1/20 0.47
▸ SLC6A4 P31645 1/20 0.45
▸ DRD2 P14416 2/20 0.45
▸ DRD1 P21728 1/20 0.45
▸ SIGMAR1 Q99720 4/20 0.41
▸ PRCP P42785 1/20 0.40
▸ MAOA P21397 2/20 0.40
▸ PDE5A O76074 1/20 0.39
▸ KIF11 P52732 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ ESR1 P03372 2/20 0.38
▸ PGR P06401 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ HTR5A P47898 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13877241 0.83 SLC6A4 (0.47) ABCB1ABCG2SLC6A4MAOAPDE5A
SCHEMBL26423539 0.77 ESR1 (0.39) ABCB1ABCG2SLC6A4ESR1HTR5A
SCHEMBL14627593 0.76 SLC6A4 (0.48) ABCB1ABCG2SLC6A4MAOAMAOB
SCHEMBL16373177 0.74 ABCB1 (0.41) ABCB1ABCG2DRD2DRD1SIGMAR1
SCHEMBL16373146 0.73 SIGMAR1 (0.71) ABCB1ABCG2SIGMAR1KIF11ESR1
SCHEMBL13877240 0.69 SLC6A4 (0.46) SLC6A4MAOAMAOBCYP1A2CYP2D6
SCHEMBL10689191 0.68 SLC6A4 (0.46) ABCB1ABCG2SLC6A4DRD1MAOA
SCHEMBL11184992 0.68 CYP3A4 (0.41) ABCB1ABCG2SLC6A4PDE5ACYP1A2
SCHEMBL10686601 0.68 SLC6A4 (0.47) ABCB1ABCG2SLC6A4MAOAMAOB
SCHEMBL13877239 0.68 SLC6A4 (0.43) SLC6A4MAOAMAOBPGRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014207241-A1 NEW Na-SUBSTITUTED CARBOLINE COMPOUNDS USABLE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES ALZPROTECT (FR) 2014-12-31 — — WO disclosed
Send feedback